Literature DB >> 33401948

The insulin-degrading enzyme as a link between insulin and neuropeptides metabolism.

Dorota Wacławczyk1, Jerzy Silberring1, Giuseppe Grasso2.   

Abstract

We have applied a recently developed HPLC-MS enzymatic assay to investigate the cryptic peptides generated by the action of the insulin-degrading enzyme (IDE) on some neuropeptides (NPs) involved in the development of tolerance and dependence to opioids. Particularly, the tested NPs are generated from the NPFF precursor (pro-NPFF (A)): NPFF (FLFQPQRF) and NPAF (AGEGLSSPFWSLAAPQRF). The results show that IDE is able to cleave NPFF and NPAF, generating specific cryptic peptides. As IDE is also responsible for the processing of many other peptides in the brain (amyloid beta protein among the others), we have also performed competitive degradation assays using mixtures of insulin and the above mentioned NPs. Data show that insulin is able to slow down the degradation of both NPs tested, whereas, surprisingly, NPAF is able to accelerate insulin degradation, hinting IDE as the possible link responsible of the mutual influence between insulin and NPs metabolism.

Entities:  

Keywords:  Insulin-degrading enzyme; diabetes; neuropeptides; opiods

Mesh:

Substances:

Year:  2021        PMID: 33401948      PMCID: PMC7801110          DOI: 10.1080/14756366.2020.1850712

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  29 in total

1.  Gene for pain modulatory neuropeptide NPFF: induction in spinal cord by noxious stimuli.

Authors:  F S Vilim; A A Aarnisalo; M L Nieminen; M Lintunen; K Karlstedt; V K Kontinen; E Kalso; B States; P Panula; E Ziff
Journal:  Mol Pharmacol       Date:  1999-05       Impact factor: 4.436

Review 2.  Multiple functions of insulin-degrading enzyme: a metabolic crosslight?

Authors:  Grazia R Tundo; Diego Sbardella; Chiara Ciaccio; Giuseppe Grasso; Magda Gioia; Andrea Coletta; Fabio Polticelli; Donato Di Pierro; Danilo Milardi; Peter Van Endert; Stefano Marini; Massimo Coletta
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-06-21       Impact factor: 8.250

3.  Cryptides: functional cryptic peptides hidden in protein structures.

Authors:  Nobuhiko Ueki; Kazuya Someya; Yuko Matsuo; Kaori Wakamatsu; Hidehito Mukai
Journal:  Biopolymers       Date:  2007       Impact factor: 2.505

Review 4.  Metal complexes and metalloproteases: targeting conformational diseases.

Authors:  Giuseppe Grasso; Sylvestre Bonnet
Journal:  Metallomics       Date:  2014-08       Impact factor: 4.526

Review 5.  Neuropeptide FF and modulation of pain.

Authors:  P Panula; E Kalso; M Nieminen; V K Kontinen; A Brandt; A Pertovaara
Journal:  Brain Res       Date:  1999-11-27       Impact factor: 3.252

Review 6.  Mass spectrometry is a multifaceted weapon to be used in the battle against Alzheimer's disease: Amyloid beta peptides and beyond.

Authors:  Giuseppe Grasso
Journal:  Mass Spectrom Rev       Date:  2018-06-15       Impact factor: 10.946

7.  Biological activity of a fragment of insulin.

Authors:  William C Duckworth; Janet Fawcett; Brian T Tsui; Robert G Bennett; Frederick G Hamel
Journal:  Biochem Biophys Res Commun       Date:  2004-06-11       Impact factor: 3.575

8.  The insulin degrading enzyme activates ubiquitin and promotes the formation of K48 and K63 diubiquitin.

Authors:  G Grasso; V Lanza; G Malgieri; R Fattorusso; A Pietropaolo; E Rizzarelli; D Milardi
Journal:  Chem Commun (Camb)       Date:  2015-09-14       Impact factor: 6.222

9.  Substrate activation of insulin-degrading enzyme (insulysin). A potential target for drug development.

Authors:  Eun-Suk Song; Maria Aparecida Juliano; Luiz Juliano; Louis B Hersh
Journal:  J Biol Chem       Date:  2003-10-02       Impact factor: 5.157

10.  IDE Degrades Nociceptin/Orphanin FQ through an Insulin Regulated Mechanism.

Authors:  Gabriele Antonio Zingale; Francesco Bellia; Ikhlas Mohamed Mohamud Ahmed; Przemyslaw Mielczarek; Jerzy Silberring; Giuseppe Grasso
Journal:  Int J Mol Sci       Date:  2019-09-10       Impact factor: 5.923

View more
  1 in total

1.  Neuroprotective Effect of Carnosine Is Mediated by Insulin-Degrading Enzyme.

Authors:  Alessia Distefano; Giuseppe Caruso; Valentina Oliveri; Francesco Bellia; Diego Sbardella; Gabriele Antonio Zingale; Filippo Caraci; Giuseppe Grasso
Journal:  ACS Chem Neurosci       Date:  2022-04-26       Impact factor: 5.780

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.